Veradermics, Incorporated beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging -67.9% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.58 | $-0.58 | +0.0% | Beat | |
| Q1 FY26 | $-0.56 | $-1.32 | -135.7% | Miss |
Back to MANE overview · MANE holders · MANE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.